Clinical Trial Update: A Placebo-controlled Crossover Trial Using Cyproheptadine To Treat Children With Functional Abdominal Pain [Phase 2]

View source ↗

Summary

A Phase 2 placebo-controlled crossover trial evaluating cyproheptadine for functional abdominal pain in children was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Abdominal Pain

Drugs mentioned

• Cyproheptadine (cyproheptadine)

Snippet

Sponsor: University of Michigan | Conditions: Functional Abdominal Pain | Phase 2 | Status: TERMINATED | Results posted: 2017-06-21